Hit-to-lead optimization of amino-carboxamide benzothiazoles as LSD1 inhibitors

被引：0
|
作者：
Du’a Al bustanji
Soraya Alnabulsi
Enas A. Al-Hurani
机构：
[1] Jordan University of Science and Technology,Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy
[2] P.O. Box 3030,undefined
来源：
Medicinal Chemistry Research | 2023年 / 32卷
关键词：
LSD1 enzyme; hit-to-lead optimization; anticancer; structure-activity relationship; amino-carboxamide benzothiazoles.;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：910 / 929
页数：19
相关论文
共 50 条
  • [41] Predicting binding energies of CDK6 inhibitors in the hit-to-lead process
    Delgado-Soler, Laura
    Arinez-Soriano, Javier
    Granadino-Roldan, Jose M.
    Rubio-Martinez, Jaime
    THEORETICAL CHEMISTRY ACCOUNTS, 2011, 128 (4-6) : 807 - 823
  • [42] Antitumor activity of LSD1 inhibitors in lung cancer
    Mohammad, Helai P.
    Kruger, Ryan G.
    MOLECULAR & CELLULAR ONCOLOGY, 2016, 3 (02)
  • [43] Discovery of potent and selective rhodanine type IKKβ inhibitors by hit-to-lead strategy
    Song, Hyeseung
    Lee, Yun Suk
    Roh, Eun Joo
    Seo, Jae Hong
    Oh, Kwang-Seok
    Lee, Byung Ho
    Han, Hogyu
    Shin, Kye Jung
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (17) : 5668 - 5674
  • [44] Natural products as LSD1 inhibitors for cancer therapy
    Fang, Yuan
    Yang, Chao
    Yu, Zhiqiang
    Li, Xiaochuan
    Mu, Qingchun
    Liao, Guochao
    Yu, Bin
    ACTA PHARMACEUTICA SINICA B, 2021, 11 (03) : 621 - 631
  • [45] Discovery and hit-to-lead optimization of 2,6-diaminopyrimidine inhibitors of interleukin-1 receptor-associated kinase 4
    McElroy, William T.
    Seganish, W. Michael
    Herr, R. Jason
    Harding, James
    Yang, Jinhai
    Yet, Larry
    Komanduri, Venukrishnan
    Prakash, Koraboina Chandra
    Lavey, Brian
    Tulshian, Deen
    Greenlee, William J.
    Sondey, Christopher
    Fischmann, Thierry O.
    Niu, Xiaoda
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (09) : 1836 - 1841
  • [46] Natural products as LSD1 inhibitors for cancer therapy
    Yuan Fang
    Chao Yang
    Zhiqiang Yu
    Xiaochuan Li
    Qingchun Mu
    Guochao Liao
    Bin Yu
    Acta Pharmaceutica Sinica B, 2021, 11 (03) : 621 - 631
  • [47] LSD1 inhibitors from the roots of Pueraria lobata
    Tian, Meng-Ru
    Du, Kun
    Zhi, Yan-Le
    Xue, Gui-Min
    Zhao, Zhen-Zhu
    Si, Ying-Ying
    Chen, Hui
    Sun, Yan-Jun
    Feng, Wei-Sheng
    Ma, Jin-Lian
    JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2023, 25 (01) : 44 - 52
  • [48] Advances toward LSD1 inhibitors for cancer therapy
    Fu, Xiaoli
    Zhang, Peng
    Yu, Bin
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (11) : 1227 - 1242
  • [49] Synthesis of Carboxamide-Containing Tranylcypromine Analogues as LSD1 (KDM1A) Inhibitors Targeting Acute Myeloid Leukemia
    Teresa Borrello, Maria
    Benelkebir, Hanae
    Lee, Adam
    Hin Tam, Chak
    Shafat, Manar
    Rushworth, Stuart A.
    Bowles, Kristian M.
    Douglas, Leon
    Duriez, Patrick J.
    Bailey, Sarah
    Crabb, Simon J.
    Packham, Graham
    Ganesan, A.
    CHEMMEDCHEM, 2021, 16 (08) : 1316 - 1324
  • [50] Trends in Hit-to-Lead Optimization Following DNA-Encoded Library Screens
    Reiher, Christopher A.
    Schuman, David P.
    Simmons, Nicholas
    Wolkenberg, Scott E.
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (03): : 343 - 350
12345